Northwest Biotherapeutics (“NW Bio”) has entered into agreements with a large multi-national corporation for a package transaction involving the Company’s property located near Cambridge, UK.     Under the agreements, NW Bio will sell most of its UK property to the multi-national corporation. The Company will receive £37.5 million (approximately $47.3 million) cash payment at closing, and will retain ownership of 17 acres of the property, which are excluded from the sale and ...